Skip to main content
Elsevier
View Cart
My account

Books in Carcinogenesis

BooksJournals

    • Proteomics: A Promising Approach for Cancer Research

      • 1st Edition
      • January 1, 2026
      • Muneeb U Rehman + 2 more
      • English
      • Paperback
        9 7 8 0 4 4 3 2 3 9 0 8 3
      • eBook
        9 7 8 0 4 4 3 2 3 9 0 7 6
      Proteomics: A Promising Approach for Cancer Research Volume 2 Proteome signaling dysregulation in cancer, therapeutic interventions, and future perspectives provides an updated overview of scientific knowledge, achievements, and findings in the field of cancer proteomics. The field of cancer proteomics is very dynamic, with emerging trends specifically related to clinical solutions. The book content was developed to help readers get up to speed on the topic and easily apply learnings into research or clinical practice.Volume 2 covers proteome signaling, their dysregulation to therapeutics options and future prospects in 17 different signaling pathways. It capitalizes the enormous interest in proteomics among academics and gives new viewpoints on this topic in cancer treatment. It is a valuable resource for cancer researchers, oncologists, graduate students, and members of biomedical field who are interested in the potential of proteomics in cancer research and treatment.

    • Principles of Immunotherapy in Breast and Gastrointestinal Cancers

      • 1st Edition
      • August 20, 2024
      • Michele Ghidini
      • English
      • Hardback
        9 7 8 0 4 4 3 1 3 3 7 6 3
      • eBook
        9 7 8 0 4 4 3 1 3 3 7 5 6
      Principles of Immunotherapy in Breast and Gastrointestinal Cancers: Activity, Mechanisms of Resistance, and New Sensitization Strategies presents updated research findings on immunotherapy, with a special focus on the mechanisms of resistance of those cancer types and how to overcome them.The book discusses topics such as tumor cell-intrinsic and -extrinsic mechanisms of cancer resistance to immunotherapy; the role of currently available biomarkers; strategies to overcome therapeutic resistance; sensitizing agents for cancer resistance to cell-mediated immunotherapy; and immunotherapeutic approaches, mechanisms of resistance, and sensitizing strategies in gastroesophageal and biliopancreatic tumors and colorectal cancer.It is a valuable resource for researchers, students, and members of the biomedical and medical fields who want to learn more about resistance to immunotherapy and how to overcome it.

    • Onco-Palliative Care Essentials

      • 1st Edition
      • June 7, 2024
      • Azar Naveen Saleem + 2 more
      • English
      • Paperback
        9 7 8 0 4 4 3 1 3 4 5 1 7
      • eBook
        9 7 8 0 4 4 3 1 3 4 5 2 4
      Onco-Palliative Care Essentials gives insight into the much-needed specialty to improve the quality of life of cancer patients. With a strong focus on the fundamental essentials of onco-palliative care, this book covers real-life cases with challenging cultural, existential, and social aspects.This book introduces the field of onco-palliative care to the reader, focusing on managing complex aspects associated with cancer and its treatment. It also helps the reader regarding approaches for “end of life care and discussion.” This book concludes with challenging care scenarios.Onco-Palli... Care Essentials is a very useful reference for all who are involved in cancer and palliative care, as well as those who care for cancer and terminally ill patients.

    • Functionalized Nanomaterials for Cancer Research

      • 1st Edition
      • March 21, 2024
      • Hamed Barabadi + 2 more
      • English
      • Paperback
        9 7 8 0 4 4 3 1 5 5 1 8 5
      • eBook
        9 7 8 0 4 4 3 1 5 5 1 9 2
      Functionalized Nanomaterials for Cancer Research: Applications in Treatments, Tools and Devices presents an in-depth and step-by-step description of knowledge on functionalized nanomaterials for cancer research, including treatment and future developments as well as their impact on patients’ overall outcomes. The book discusses functionalized nanoplatforms for cancer detection and imaging, interactions between nanomaterials and cancer cells, and drug resistant malignancies. The book's chapters are organized in a manner that can be readily adopted as sources for new and further studies by highlighting the main in vitro and in vivo nano-therapeutic achievements on cancer. Additionally, current trends on functionalized nanomaterials for cancer research and commercial scale opportunities are discussed. This is a valuable resource for researchers, oncologists, students, and members of the biomedical and medical fields who want to learn more about the potential of nanotechnology in cancer research and treatment.

    • Epigenetic Cancer Therapy

      • 2nd Edition
      • May 3, 2023
      • Steven Gray
      • English
      • Paperback
        9 7 8 0 3 2 3 9 1 3 6 7 6
      • eBook
        9 7 8 0 3 2 3 9 1 7 1 5 5
      Epigenetic Cancer Therapy, Second Edition provides a comprehensive discussion of healthy and aberrant epigenetic biology, along with new discoveries to improve our understanding of cancer epigenetics and therapeutics. The book encompasses large-scale intergovernmental initiatives, as well as recent findings across cancer stem cells, rational drug design, clinical trials, and chemopreventative strategies. As a whole, the work articulates and raises the profile of epigenetics as a therapeutic option in the future management of cancer. Since the publication of the first edition of this book, the field of epigenetics has undergone significant change. New epigenetic therapies have been designed and approved for clinical use. Our knowledge of the plasticity of the epigenome in cancer and disease has expanded dramatically, with increasing evidence linking pollution to epigenetic changes in cancer development. This second edition has been fully updated to address these changes, along with promising therapeutic programs such as CRISPR/Cas9 mediated approaches, CAR-T based therapies, epigenetic priming, histone modifications, and similar, transformative advances across synthetic biology and cellular engineering.

    • Treatment Landscape of Targeted Therapies in Oncology

      • 1st Edition
      • July 29, 2023
      • Pawan Kumar Maurya + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 1 6 0 3 4 9
      • eBook
        9 7 8 0 4 4 3 1 6 0 3 5 6
      Treatment Landscape of Targeted Therapies in Oncology: Challenges and Opportunities provides up-to-date knowledge on antitumor-targeted therapies and immunotherapy. The book's chapters are written by researchers dynamically working/focusing on cancer treatment. The content is designed to help those who are new to the field (beginners) and various specialized scientists and researchers involved in cancer research. For decades, the hallmark of cancer treatment has been conventional chemotherapy. But with the rapid increase in our understanding of the immune system, more and more small molecules, peptides, recombinant antibodies, vaccines and cellular therapeutic modalities are being applied to manipulate the immune response for cancer treatment.

    • Proteomics

      • 1st Edition
      • February 14, 2023
      • Shafat Ali + 2 more
      • English
      • Paperback
        9 7 8 0 3 2 3 9 5 0 7 2 5
      • eBook
        9 7 8 0 3 2 3 9 5 0 7 3 2
      Proteomics: A Promising Approach for Cancer Research provides an updated overview of scientific knowledge, achievements and findings in the field of cancer proteomics. The book discusses topics such as the use of proteomics in cancer biology and drug discovery, its role in surgical oncology, applications of mass spectrometry, target proteomics, single-cell proteomics, and next-generation proteomics. In addition, it discusses proteomics and phosphor-proteomics in cancer precision medicine; translation of proteomics research into clinical application; and challenges and future developments of the field. This will be a valuable resource for cancer researchers, oncologists, graduate students, and members of biomedical field who are interested in the potential of proteomics in cancer research and treatment. The field of cancer proteomics is very dynamic, with emerging trends related to clinical solutions developed in recent years, therefore this book's content helps readers get up-to-speed on the topic to easily apply learnings into their research or clinical practice.

    • Diagnosis and Management of Hereditary Cancer

      • 1st Edition
      • March 20, 2021
      • John W. Henson + 1 more
      • English
      • Hardback
        9 7 8 0 3 2 3 9 0 7 4 6 0
      • eBook
        9 7 8 0 3 2 3 8 8 5 8 2 9
      Many hereditary cancer syndromes are linked to alterations in single genes. Detection and clinical interpretation of these alterations can guide cancer risk reduction for patients and their families through screening, prophylactic measures, and other strategies. Diagnosis and Management of Hereditary Cancer summarizes hereditary syndromes and their associated cancers and genes. The information is presented in 50 practice-enhancing tables that relate clinical, genetic, diagnostic, and management aspects in a manner that has previously not been available in a single reference. Intended to guide the specialist as well the novice, this volume will elevate the care of hereditary cancer patients and their families.

    • Cancer

      • 2nd Edition
      • January 14, 2021
      • Victor R Preedy + 1 more
      • English
      • Hardback
        9 7 8 0 1 2 8 1 9 5 4 7 5
      • eBook
        9 7 8 0 1 2 8 1 9 5 6 3 5
      Cancer: Oxidative Stress and Dietary Antioxidants, Second Edition, covers the science of oxidative stress in cancer and the potentially therapeutic usage of natural antioxidants in the diet or food matrix. The processes within the science of oxidative stress are described in concert with other processes, such as apoptosis, cell signaling, and receptor-mediated responses. This approach recognizes that diseases are often multifactorial and that oxidative stress is a single component. Other sections cover new organ site tumors—skin and liver cancer, the role of polymorphisms, cytochrome p450s, COX gene, fatty acids, apoptosis, T cells and mitochondria, prevention/protectio... with anthocyanins, esculetin, nanoparticles, and more. This book is a valuable resource for cancer researchers, oncologists, nutritionists and other members of the biomedical field who are interested in enhancing treatment outcome, improving the quality of life of patients, and developing new treatments in the fight against cancer.

    • Bone Cancer

      • 3rd Edition
      • September 22, 2021
      • Dominique Heymann
      • English
      • Hardback
        9 7 8 0 1 2 8 2 1 6 6 6 8
      • eBook
        9 7 8 0 3 2 3 8 9 9 9 0 1
      Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside, Third Edition comprehensively investigates key discoveries in the field of bone biology. New aspects of bone cancer biology are treated in new chapters covering exosomes, autophagy, and metabolism. These have led to the development of entirely new areas for investigation, such as therapies which combine surgery and biological approaches. The Third Edition expands on the original overview of bone cancer development (physiology and pathophysiology), with 40% new material. Each chapter has been written by internationally recognized specialists on the bone cancer microenvironment, bone metastases, osteoclast biology in bone cancer, proteomics, bone niche, circulating tumor cells, and clinical trials. Given the global prevalence of breast and prostate cancers, knowledge of bone biology has become essential for everyone within the medical and cancer research communities. Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside continues to offer the only translational reference to cover all aspects of primary bone cancer and bone metastases. This revision opens the door to myeloma with two short chapters dedicated to this bone-associated disease.